Evolution of an Artificial Intelligence-Powered Application for Mammography

<b>Background:</b> The implementation of radiological artificial intelligence (AI) solutions remains challenging due to limitations in existing testing methodologies. This study assesses the efficacy of a comprehensive methodology for performance testing and monitoring of commercial-grade mammographic AI models. <b>Methods:</b> We utilized a combination of retrospective and prospective multicenter approaches to evaluate a neural network based on the Faster R-CNN architecture with a ResNet-50 backbone, trained on a dataset of 3641 mammograms. The methodology encompassed functional and calibration testing, coupled with routine technical and clinical monitoring. Feedback from testers and radiologists was relayed to the developers, who made updates to the AI model. The test dataset comprised 112 medical organizations, representing 10 manufacturers of mammography equipment and encompassing 593,365 studies. The evaluation metrics included the area under the curve (AUC), accuracy, sensitivity, specificity, technical defects, and clinical assessment scores. <b>Results:</b> The results demonstrated significant enhancement in the AI model's performance through collaborative efforts among developers, testers, and radiologists. Notable improvements included functionality, diagnostic accuracy, and technical stability. Specifically, the AUC rose by 24.7% (from 0.73 to 0.91), the accuracy improved by 15.6% (from 0.77 to 0.89), sensitivity grew by 37.1% (from 0.62 to 0.85), and specificity increased by 10.7% (from 0.84 to 0.93). The average proportion of technical defects declined from 9.0% to 1.0%, while the clinical assessment score improved from 63.4 to 72.0. Following 2 years and 9 months of testing, the AI solution was integrated into the compulsory health insurance system. <b>Conclusions:</b> The multi-stage, lifecycle-based testing methodology demonstrated substantial potential in software enhancement and integration into clinical practice. Key elements of this methodology include robust functional and diagnostic requirements, continuous testing and updates, systematic feedback collection from testers and radiologists, and prospective monitoring.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2025-03-24
DOI
https://doi.org/10.3390/diagnostics15070822
Citations
2
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
4.96
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolution of an Artificial Intelligence-Powered Application for Mammography

Kirill M. Arzamasov, Lev D. Pestrenin, Olga V. Omelyanskaya, Igor M. Shulkin et al.
2 citations
Diagnostics
AI in cancer detection
4.96
article

Evolution of an Artificial Intelligence-Powered Application for Mammography

Kirill M. Arzamasov, Lev D. Pestrenin, Olga V. Omelyanskaya, Igor M. Shulkin, Denis А. Rumyantsev, Anton V. Vladzymyrskyy, Artem Kapninskiy, E. D. Nikitin, Yuriy А. Vasilev
article en
2 citations

Abstract

<b>Background:</b> The implementation of radiological artificial intelligence (AI) solutions remains challenging due to limitations in existing testing methodologies. This study assesses the efficacy of a comprehensive methodology for performance testing and monitoring of commercial-grade mammographic AI models. <b>Methods:</b> We utilized a combination of retrospective and prospective multicenter approaches to evaluate a neural network based on the Faster R-CNN architecture with a ResNet-50 backbone, trained on a dataset of 3641 mammograms. The methodology encompassed functional and calibration testing, coupled with routine technical and clinical monitoring. Feedback from testers and radiologists was relayed to the developers, who made updates to the AI model. The test dataset comprised 112 medical organizations, representing 10 manufacturers of mammography equipment and encompassing 593,365 studies. The evaluation metrics included the area under the curve (AUC), accuracy, sensitivity, specificity, technical defects, and clinical assessment scores. <b>Results:</b> The results demonstrated significant enhancement in the AI model's performance through collaborative efforts among developers, testers, and radiologists. Notable improvements included functionality, diagnostic accuracy, and technical stability. Specifically, the AUC rose by 24.7% (from 0.73 to 0.91), the accuracy improved by 15.6% (from 0.77 to 0.89), sensitivity grew by 37.1% (from 0.62 to 0.85), and specificity increased by 10.7% (from 0.84 to 0.93). The average proportion of technical defects declined from 9.0% to 1.0%, while the clinical assessment score improved from 63.4 to 72.0. Following 2 years and 9 months of testing, the AI solution was integrated into the compulsory health insurance system. <b>Conclusions:</b> The multi-stage, lifecycle-based testing methodology demonstrated substantial potential in software enhancement and integration into clinical practice. Key elements of this methodology include robust functional and diagnostic requirements, continuous testing and updates, systematic feedback collection from testers and radiologists, and prospective monitoring.

DiagnosticsVol. 15(7)
Sechenov University (RU), MIREA - Russian Technological University (RU)
Openalex Percentile: Top 6%
AI in cancer detection
4.96
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.